I would buy 40% at this price then if the price drops to $30-40 I'd buy the rest of the 60%
IPCA Labs CMP 2176. Looks good for X/2 entry at CMP and second X/2 entry above 2265. Targets: 2453, 2600 and 2700+ (long Term) Stop Loss: Below 1850 closing. Also there will be stock split soon 2:1 in IPCA.
The stock has broken out and retest therefore may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby. Risk Reward Ratio - 2:1 SL is placed below support zone, 200 EMA & the lower trendline. The target is placed near resistance.
Malaysia Health Index which comprise most of gloves stocks have very high positive correlation with Glove's stock price. The Index chart seem like completing its wedge /triple zig-zag pattern soon.
looks like the 5 down are about finished. Would want to see an ABC correction 1st then 5 up impulsive move B4 I could make any targets.
TDOC broke and retested downward trend line and horizontal support. It has 20 and 50 ema dynamic supports underneath (4 hour). Target would be $146 resistance which is in line with the 200 ma on the 4 hour. - HH
I rarely dabble in health service companies. But, after doing some reading I see a lot of merit in their mission, and this company could easily be worth 10X its current market capitalization if utilized by the Health service industry or acquired by an insurers to cut liability costs. Little can be distilled from available chart data, and comprehending the...
BFLY Current Price $12.20 Price Target $20 I like BFLY here, as it has over $500 million in cash following its merger with Longview, and I like that it is fully expected to be cash-flow positive by 2024.Revenue increased 40.0% to $16.5 million in Q2 2021 from $11.8 million in Q2 2020. The revenue can be traced to both product and subscription revenues. Product...
The pandemic has opened up investing opportunities in the healthcare sector. While buying stock in major companies may be attractive, I feel that investing in healthcare ETF (XLV) may be a better and more conservative option. XLV recently hit a 52 week high but as you can see it has been pulling back (perhaps in part due to the uncertainty caused by the delta...
Not financial advice but I've been working with an associate to "resurrect" his squashed grapes of a portfolio and TSOI has already doubled it's portion of the equity in that account. Without getting too deep into it, the FIbs are pretty reliable on this OTC stock so DYOR, dive in and swim!! Good luck!
Cigna (CI),D1: Support line + Bollinger bands + Harami + Oversold + Divergence + Sell off
WORX stock tested a key FIb level on Wednesday being the 50 fib line after plotting the top anchor at the recent high the first time WORX busted above the 50 fib. Before this latest round of testing, the last time WORX reached this key level it was rejected heavily. A few weeks ago, the company announced that it had regained compliance with the NASDAQ listing...
There will most likely be a 25% to 35% drop in BNTX over a very short period of time. If we gap down Tuesday then expect it to drop the whole day. Reasons: Price and volume divergence, over-extesnion of price and emotions, demand imbalances are way lower, topping formations intra-day.
Someone had asked me to chart this up two weeks ago if I recall and I'd set up a buy grid using Fibonacci, some trend lines and your basic Hi's / Low's and everything goes. I'll post the updated TA version in a bit here but we can see that at the very least, my stop market buy would have filled and a gain at the top of the Fib overlay I'd made at that time would...
Earlier this year Japara health care (JHC, bottom chart) had a take over bid, pushing the stock to higher prices, outperforming REG. The stock is typically highly correlated, and with the deviation from the mean I'm looking for a return back to the mean. I will be going long REG and potentially taking a short on JHC for a reversion.
JD HEALTH as retail pharmacy has started to be online, and notice increase of sale retail is now online multiple supported showing JD Health have been ranging near the IPO price, premature Head and Shoulder is forming up. Currently it's at lower zone, expecting as break out happening soon with the lower range support to TP1 $124 and above.. If support break we...
BFLY Current Price $12.75 Price Target $20 This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting...
BFLY Current Price $14.36 Price Target $20 $10c 10/15 ($470, 3% till breakeven) We have been in BFLY since $10. This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They...